3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 25 0 1 0 0 0 0 0999 V2000
-1.6779 -0.1121 1.9472 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9089 0.5950 -0.5398 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5477 2.0114 0.5950 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.4214 -0.0012 -0.0404 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6555 0.3890 -1.4105 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9063 -0.3131 0.4426 C 0 0 1 0 0 0 0 0 0 0 0 0
-2.1593 0.2637 -1.5517 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6843 0.5626 -0.1526 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5661 0.0916 0.7476 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4411 -1.5767 -0.2381 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7927 0.8865 0.1745 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5678 -2.7966 0.0263 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1333 -0.2574 -2.1193 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.3317 1.4263 -1.5445 H 0 0 0 0 0 0 0 0 0 0 0 0
0.8810 -0.4693 1.5273 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.4212 -0.7661 -1.8256 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.5726 0.9298 -2.3142 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.6112 0.0239 0.0580 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.8293 1.6366 -0.0005 H 0 0 0 0 0 0 0 0 0 0 0 0
1.5487 -1.4473 -1.3214 H 0 0 0 0 0 0 0 0 0 0 0 0
2.4463 -1.7961 0.1451 H 0 0 0 0 0 0 0 0 0 0 0 0
0.4396 -2.9626 1.1007 H 0 0 0 0 0 0 0 0 0 0 0 0
1.0339 -3.6907 -0.4001 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.4219 -2.6903 -0.4284 H 0 0 0 0 0 0 0 0 0 0 0 0
3.4704 1.3869 -0.6808 H 0 0 0 0 0 0 0 0 0 0 0 0
1 9 2 0 0 0 0
2 11 1 0 0 0 0
2 25 1 0 0 0 0
3 11 2 0 0 0 0
4 5 1 0 0 0 0
4 6 1 0 0 0 0
4 9 1 0 0 0 0
5 7 1 0 0 0 0
5 13 1 0 0 0 0
5 14 1 0 0 0 0
6 10 1 0 0 0 0
6 11 1 0 0 0 0
6 15 1 0 0 0 0
7 8 1 0 0 0 0
7 16 1 0 0 0 0
7 17 1 0 0 0 0
8 9 1 0 0 0 0
8 18 1 0 0 0 0
8 19 1 0 0 0 0
10 12 1 0 0 0 0
10 20 1 0 0 0 0
10 21 1 0 0 0 0
12 22 1 0 0 0 0
12 23 1 0 0 0 0
12 24 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
2-(2-oxopyrrolidin-1-yl)butanoic acid
4.2 InChl
InChI=1S/C8H13NO3/c1-2-6(8(11)12)9-5-3-4-7(9)10/h6H,2-5H2,1H3,(H,11,12)
4.3 InChlKey
IODGAONBTQRGGG-UHFFFAOYSA-N
4.4 Canonical SMILES
CCC(C(=O)O)N1CCCC1=O
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病